Subject(s)

Antigens, Human Platelet/immunology , Autoantibodies/immunology , Eptifibatide/adverse effects , Platelet Aggregation Inhibitors/adverse effects , Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors , Purpura, Thrombocytopenic, Idiopathic/etiology , ST Elevation Myocardial Infarction/blood , Thrombosis/etiology , Arginine/analogs & derivatives , Arginine/therapeutic use , Aspirin/therapeutic use , Combined Modality Therapy , Coronary Thrombosis/etiology , Coronary Thrombosis/surgery , Drug Substitution , Drug Therapy, Combination , Eptifibatide/immunology , Eptifibatide/therapeutic use , Humans , Male , Middle Aged , Percutaneous Coronary Intervention , Pipecolic Acids/therapeutic use , Platelet Aggregation Inhibitors/immunology , Platelet Aggregation Inhibitors/therapeutic use , Platelet Glycoprotein GPIIb-IIIa Complex/immunology , Platelet Transfusion , Purpura, Thrombocytopenic, Idiopathic/immunology , Purpura, Thrombocytopenic, Idiopathic/therapy , ST Elevation Myocardial Infarction/drug therapy , ST Elevation Myocardial Infarction/therapy , Shock, Cardiogenic/etiology , Stents/adverse effects , Sulfonamides/therapeutic use , Thrombectomy , Thrombolytic Therapy , Thrombosis/drug therapy , Ticagrelor/therapeutic use , Warfarin/therapeutic use